Extreme Pathway Analysis of Human Red Blood Cell Metabolism
Overview
Authors
Affiliations
The development of high-throughput technologies and the resulting large-scale data sets have necessitated a systems approach to the analysis of metabolic networks. One way to approach the issue of complex metabolic function is through the calculation and interpretation of extreme pathways. Extreme pathways are a mathematically defined set of generating vectors that describe the conical steady-state solution space for flux distributions through an entire metabolic network. Herein, the extreme pathways of the well-characterized human red blood cell metabolic network were calculated and interpreted in a biochemical and physiological context. These extreme pathways were divided into groups based on such criteria as their cofactor and by-product production, and carbon inputs including those that 1) convert glucose to pyruvate; 2) interchange pyruvate and lactate; 3) produce 2,3-diphosphoglycerate that binds to hemoglobin; 4) convert inosine to pyruvate; 5) induce a change in the total adenosine pool; and 6) dissipate ATP. Additionally, results from a full kinetic model of red blood cell metabolism were predicted based solely on an interpretation of the extreme pathway structure. The extreme pathways for the red blood cell thus give a concise representation of red blood cell metabolism and a way to interpret its metabolic physiology.
Genome-scale models in human metabologenomics.
Mardinoglu A, Palsson B Nat Rev Genet. 2024; 26(2):123-140.
PMID: 39300314 DOI: 10.1038/s41576-024-00768-0.
Nemkov T, Stephenson D, Earley E, Keele G, Hay A, Key A Cell Metab. 2024; 36(9):1979-1997.e13.
PMID: 38964323 PMC: 11374506. DOI: 10.1016/j.cmet.2024.06.007.
Proteomes of plasmodium knowlesi early and late ring-stage parasites and infected host erythrocytes.
Anderson D, Peterson M, Lapp S, Galinski M J Proteomics. 2024; 302:105197.
PMID: 38759952 PMC: 11357705. DOI: 10.1016/j.jprot.2024.105197.
Schurr A Int J Mol Sci. 2024; 25(3).
PMID: 38338711 PMC: 10855259. DOI: 10.3390/ijms25031433.
The role of CD47 in non-neoplastic diseases.
Wang C, Feng Y, Patel D, Xie H, Lv Y, Zhao H Heliyon. 2023; 9(12):e22905.
PMID: 38125492 PMC: 10731077. DOI: 10.1016/j.heliyon.2023.e22905.